0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
At-Home Testing Market by Test Type (Glucose Test Kits, Infectious Diseases Test Kits, Pregnancy Test Kits, Cholesterol Test Strips, Drugs of Abuse Test Kits, Coagulation Monitoring Tests, Others), by Age Group (Pediatric, Adult, Geriatric), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031
Published Date: January 2023
|
Report Code: ALLI-Manu-1F72
Home | Market Reports | Health
At Home Testing Market

At-Home Testing Market by Test Type (Glucose Test Kits, Infectious Diseases Test Kits, Pregnancy Test Kits, Cholesterol Test Strips, Drugs of Abuse Test Kits, Coagulation Monitoring Tests, Others), by Age Group (Pediatric, Adult, Geriatric), by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies): Global Opportunity Analysis and Industry Forecast, 2021-2031

Code: ALLI-Manu-1F72
Report
January 2023
238 Pages
Allied Market Research
Region:
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

At-Home Testing Market 

The global At-Home Testing Market Size was valued at USD 16,663.94 million in 2021 and is estimated to surpass USD 45,582.24 million by 2031, growing at a CAGR of 10.5% from 2022 to 2031.

 at home testing market report

At-home tests also called self-tests or home-use tests are typically sold over the counter (OTC) and allow users to test self-collected specimens and interpret the results on their own without the help of trained health professionals. These types of tests differ from home-collection tests, which require users to collect samples at home, mail them to a laboratory or clinic for analysis, and obtain the results by telephone a few days later. Additionally, it has tools for continuously checking and managing diabetic patients' health. At-home tests can be taken in the comfort of own home and are extremely cost-effective. The procedures, packing, and instructions have all been made simpler to help people through the exam-taking process. There are several at-home test kits available, including those for HIV testing, pregnancy testing, diabetes testing, ovulation testing, coagulation monitoring test kits, and testing for infectious diseases including malaria, and others. Blood, urine, and oral fluid can all be used as samples for these quick tests that can be done at home.

Covid-19 Impact On At-Home Testing Market 

The at-home testing market was slightly increased during the lockdown period owing to increased demand for self-testing kits. The COVID-19 pandemic increases the demand and production of at-home testing kits such as glucose monitoring devices, infectious diseases test kits, and other at-home testing kits, which increases the total net revenue of firms that deal in the manufacturing and distribution of testing and diagnostic devices. Therefore, to reduce the spread of the coronavirus, people are adopting more self-help testing kits due to several restrictions in place.

The market was analyzed qualitatively and quantitatively from 2020-2021. Most of the growth during this period was derived from the Asia-Pacific owing to the rise in prevalence of chronic diseases and the increase in the adoption of at-home testing kits in disease diagnosis at home, improving health awareness, rising disposable incomes, as well as the well-established presence of domestic companies in the region.  

At-Home Testing Market Trends

The rise in technological advancement for the development of the latest at-home testing kits and devices and the rise in the prevalence of diabetes in increases the need for rapid testing kits creating an opportunity for the at-home testing market. In addition, growth of the at-home testing market is expected to be driven by the rise in awareness about the advantages offered by home-testing devices, and an increase in the demand for HIV testing kits, diabetes kits, and various others. Furthermore, the easy availability of self-testing kits at online stores and pharmacies without any prescription boosts the market growth. Moreover, the increase in the number of R&D activities in the field of at-home testing kits or medical devices enhanced healthcare services, and significant investments by the government to improve healthcare infrastructure has become a vital tool for small and large businesses globally, due to the rise in adoption for personalized self-assessing kits for the diagnosis of HIV disease. This is attributed to further support At-Home Testing Market Growth. As demand for At-home testing is not only limited to developed countries but is also being witnessed in developing countries, such as China, Brazil, and India, which fuel the growth of the market.

Furthermore, COVID-19 pandemic increases awareness among people regarding the use of self-testing kits. The COVID-19 pandemic increases the demand and production of at-home testing kits such as glucose monitoring devices, infectious diseases test kits, and other at-home testing kits, which increases the total net revenue of firms that deal in the manufacturing and distribution of testing and diagnostic devices. Therefore, to reduce the spread of the coronavirus, people are adopting more self-help testing kits due to several restrictions in place.

Furthermore, it has turned out to be a benefit for both hospitals and patients, as well as for pharmaceutical device manufacturers as hospitals are entirely focused on COVID-19 patients, and the patients can save hefty costs of doctor visits and medicine fees by self-testing some of the body vitals. It has become highly convenient for consumers as they can quickly know their test results at their fingertips. Thus, these factors are expected to create lucrative opportunities for the market to grow in the near future, providing profitable opportunities for key players post-COVID-19.  

At-Home Testing Market Segment Overview

The at-home testing market is segmented on the basis of test type, age group distribution channel, and region. By test type, the market is segmented into glucose tests, infectious diseases test kits, pregnancy test kits, cholesterol test strips, drug of abuse test kits, coagulation monitoring test kits, and others. By age group, it is bifurcated into a pediatric, adult, and geriatric. By distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, and online pharmacies. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

By Type

Based on test type, the market is segmented into glucose tests, infectious diseases test kits, pregnancy test kits, cholesterol test strips, drug of abuse test kits, coagulation monitoring test kits, and others. The glucose test kits segment dominated the global market in 2021 and is expected to remain dominant throughout the forecast period, owing to the rise in the prevalence of diabetes which increases the demand for home-based glucose test kits that boost the growth of the At-Home Testing Market Forecast.

By Age Group

By age group, at-home testing market is segregated into pediatric, adult, and geriatric. The adult segment dominated the global market in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to the fact that with the increase in the age of a person, the chances of acquiring cancer and chronic diseases increase, which increases the demand for diagnostic kits or medical devices by adult age group patients hence propelling the At-Home Testing Market Size.

By Dsitribution Channel

By distribution channel, the at-home testing market is segregated into retail pharmacies, hospital pharmacies, and online pharmacies. The retail pharmacies segment has the largest At-Home Testing Market Share in 2021 and is anticipated to continue this trend during the forecast period. This is attributed to increasing investment in retail pharmacies and a shift towards more organized markets, and increased awareness of wellness and health, which increases the demand for at-home testing kits are the key factors that drive the growth of the market in upcoming years. 

By Region

By region, the at-home testing market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for a major share of the at-home testing market in 2021 and is expected to maintain its dominance during the forecast period. The presence of several major players, such as ACON Laboratories Inc, Cardinal Health Inc, Biomerieux SA, Abbott Laboratories, F. Hoffmann-La-Roche Ltd, B. Braun Melsungen AG, and the advancement in technology of at-home testing devices in the region drive the growth of the market. In addition, the surge in the adoption of self-testing kits owing to the pandemic, the rise in awareness about the importance of HIV diagnosis, increase in the prevalence of diabetes in the region, are the key factor that drives the growth of the market. Furthermore, product launches, mergers, collaborations, and acquisitions adopted by the key players in this region boost the growth of the market

Asia-Pacific is expected to grow at the highest rate during the forecast period. The At-Home Testing Industry growth in this region is attributable to the presence of pharmaceutical companies in the region as well as the rise in the geriatric population of the countries, such as China and India. Moreover, the rise in demand for self-testing kits owing to an increase in awareness amongst people, and advances in the medical device sector, drive the growth of the market. Furthermore, the Asia-Pacific region exhibits the largest medicine supply and the largest pharmaceutical industry with the availability of technologically advanced medical devices in abundance, which can be easily accessed by consumers. This, in turn, drives the growth of the market. Asia-Pacific offers profitable opportunities for key players operating in the at-home testing market, thereby registering the fastest growth rate during the forecast period, owing to the growing infrastructure of industries, rising disposable incomes, as well as the well-established presence of domestic companies in the region. In addition, increased technological innovations and heavy funding by government and private organizations, and increased investment by companies in R&D activities are expected to provide great opportunities for the growth of the market in this region.  

Product Launch in the Market

  • In July 2021, Abbott launched a COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms.
  • In June 2022, Genes2Me Pvt. Ltd., one of the leading IVD solution manufacturer in India, launched CoviEasy self-test rapid antigen test kit for COVID-19 that is easy to use and give faster results in 10 minutes. Backed by an AI-driven mobile app, this IVD product delivers a high level of sensitivity and concordance of more than 98% accuracy.
  • In November 2022 Israel-based start-up invented a novel pregnancy test kit, SalistickTM which is the first rapid saliva-based pregnancy test with a new and improved user experience and high accuracy for early pregnancy detection. The kit is based on revolutionary technology which detects the pregnancy hormone β-hCG in saliva.

Scope of At-Home Testing Market Report

Report Metric Details
Report Name At-Home Testing Market
The market size in 2021 USD 16,663.94 Million
The revenue forecast in 2031 USD 45,582.24 Million
Growth Rate CCAGR of 10.5%
Market size available for years 2022-2031
Forecast units Value (USD)
Segments covered Type, Application, Industry, Regions
Report coverage Revenue & volume forecast, company share, competitive landscape, growth factors, and trends
Geographic regions covered North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Frequently Asked Questions About This Report 

1. Do you provide chapter wise report data? 

Ans. Yes, we do provide the option to buy chapters in a report. We also can customize the report based on your specific requirements.

2. How big is the At Home Testing Market?

Ans. The global air taxi market size is expected to be USD 817.50 Million by 2021, and is projected to reach USD 6.63 Billion by 2030, registering a CAGR of 26.2% from 2021 to 2030.

3. Does the report provides covid-19 impact analysis?

Ans. Yes, the report includes a COVID-19 impact analysis. Also, it is further extended into every individual segment of the report.

CHAPTER 1:INTRODUCTION

    • 1.1.Report description
    • 1.2.Key market segments
    • 1.3.Key benefits to the stakeholders
    • 1.4.Research Methodology
      • 1.4.1.Secondary research
      • 1.4.2.Primary research
      • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study
    • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope
    • 3.2.Key findings
      • 3.2.1.Top investment pockets
    • 3.3.Porter’s five forces analysis
    • 3.4.Market dynamics
      • 3.4.1.Drivers
        • 3.4.1.1. Increasing awareness about the importance of at-home testing kits
        • 3.4.1.2. Rise in technological advancement
        • 3.4.1.3. Easy availability of self-testing kits at pharmacies


      • 3.4.2.Restraints
        • 3.4.2.1. Inaccuracy of results by self-testing kits


      • 3.4.3.Opportunities
        • 3.4.3.1. High growth potential in developing economies

 

    • 3.5.COVID-19 Impact Analysis on the market

CHAPTER 4: AT-HOME TESTING MARKET, BY TEST TYPE

    • 4.1 Overview
      • 4.1.1 Market size and forecast
    • 4.2. Glucose Test Kits
      • 4.2.1 Key market trends, growth factors and opportunities
      • 4.2.2 Market size and forecast, by region
      • 4.2.3 Market share analysis by country
    • 4.3. Infectious Diseases Test Kits
      • 4.3.1 Key market trends, growth factors and opportunities
      • 4.3.2 Market size and forecast, by region
      • 4.3.3 Market share analysis by country
    • 4.4. Pregnancy Test Kits
      • 4.4.1 Key market trends, growth factors and opportunities
      • 4.4.2 Market size and forecast, by region
      • 4.4.3 Market share analysis by country
    • 4.5. Cholesterol Test Strips
      • 4.5.1 Key market trends, growth factors and opportunities
      • 4.5.2 Market size and forecast, by region
      • 4.5.3 Market share analysis by country
    • 4.6. Drugs of Abuse Test Kits
      • 4.6.1 Key market trends, growth factors and opportunities
      • 4.6.2 Market size and forecast, by region
      • 4.6.3 Market share analysis by country
    • 4.7. Coagulation Monitoring Tests
      • 4.7.1 Key market trends, growth factors and opportunities
      • 4.7.2 Market size and forecast, by region
      • 4.7.3 Market share analysis by country
    • 4.8. Others
      • 4.8.1 Key market trends, growth factors and opportunities
      • 4.8.2 Market size and forecast, by region
      • 4.8.3 Market share analysis by country

CHAPTER 5: AT-HOME TESTING MARKET, BY AGE GROUP

    • 5.1 Overview
      • 5.1.1 Market size and forecast
    • 5.2. Pediatric
      • 5.2.1 Key market trends, growth factors and opportunities
      • 5.2.2 Market size and forecast, by region
      • 5.2.3 Market share analysis by country
    • 5.3. Adult
      • 5.3.1 Key market trends, growth factors and opportunities
      • 5.3.2 Market size and forecast, by region
      • 5.3.3 Market share analysis by country
    • 5.4. Geriatric
      • 5.4.1 Key market trends, growth factors and opportunities
      • 5.4.2 Market size and forecast, by region
      • 5.4.3 Market share analysis by country

CHAPTER 6: AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL

    • 6.1 Overview
      • 6.1.1 Market size and forecast
    • 6.2. Retail Pharmacies
      • 6.2.1 Key market trends, growth factors and opportunities
      • 6.2.2 Market size and forecast, by region
      • 6.2.3 Market share analysis by country
    • 6.3. Hospital Pharmacies
      • 6.3.1 Key market trends, growth factors and opportunities
      • 6.3.2 Market size and forecast, by region
      • 6.3.3 Market share analysis by country
    • 6.4. Online Pharmacies
      • 6.4.1 Key market trends, growth factors and opportunities
      • 6.4.2 Market size and forecast, by region
      • 6.4.3 Market share analysis by country

CHAPTER 7: AT-HOME TESTING MARKET, BY REGION

    • 7.1 Overview
      • 7.1.1 Market size and forecast
    • 7.2 North America
      • 7.2.1 Key trends and opportunities
      • 7.2.2 North America Market size and forecast, by Test Type
      • 7.2.3 North America Market size and forecast, by Age Group
      • 7.2.4 North America Market size and forecast, by Distribution Channel
      • 7.2.5 North America Market size and forecast, by country
        • 7.2.5.1 U.S.
          • 7.2.5.1.1 Key market trends, growth factors and opportunities
          • 7.2.5.1.2 Market size and forecast, by Test Type
          • 7.2.5.1.3 Market size and forecast, by Age Group
          • 7.2.5.1.4 Market size and forecast, by Distribution Channel
        • 7.2.5.2 Canada
          • 7.2.5.2.1 Key market trends, growth factors and opportunities
          • 7.2.5.2.2 Market size and forecast, by Test Type
          • 7.2.5.2.3 Market size and forecast, by Age Group
          • 7.2.5.2.4 Market size and forecast, by Distribution Channel
        • 7.2.5.3 Mexico
          • 7.2.5.3.1 Key market trends, growth factors and opportunities
          • 7.2.5.3.2 Market size and forecast, by Test Type
          • 7.2.5.3.3 Market size and forecast, by Age Group
          • 7.2.5.3.4 Market size and forecast, by Distribution Channel
    • 7.3 Europe
      • 7.3.1 Key trends and opportunities
      • 7.3.2 Europe Market size and forecast, by Test Type
      • 7.3.3 Europe Market size and forecast, by Age Group
      • 7.3.4 Europe Market size and forecast, by Distribution Channel
      • 7.3.5 Europe Market size and forecast, by country
        • 7.3.5.1 Germany
          • 7.3.5.1.1 Key market trends, growth factors and opportunities
          • 7.3.5.1.2 Market size and forecast, by Test Type
          • 7.3.5.1.3 Market size and forecast, by Age Group
          • 7.3.5.1.4 Market size and forecast, by Distribution Channel
        • 7.3.5.2 France
          • 7.3.5.2.1 Key market trends, growth factors and opportunities
          • 7.3.5.2.2 Market size and forecast, by Test Type
          • 7.3.5.2.3 Market size and forecast, by Age Group
          • 7.3.5.2.4 Market size and forecast, by Distribution Channel
        • 7.3.5.3 UK
          • 7.3.5.3.1 Key market trends, growth factors and opportunities
          • 7.3.5.3.2 Market size and forecast, by Test Type
          • 7.3.5.3.3 Market size and forecast, by Age Group
          • 7.3.5.3.4 Market size and forecast, by Distribution Channel
        • 7.3.5.4 Italy
          • 7.3.5.4.1 Key market trends, growth factors and opportunities
          • 7.3.5.4.2 Market size and forecast, by Test Type
          • 7.3.5.4.3 Market size and forecast, by Age Group
          • 7.3.5.4.4 Market size and forecast, by Distribution Channel
        • 7.3.5.5 Spain
          • 7.3.5.5.1 Key market trends, growth factors and opportunities
          • 7.3.5.5.2 Market size and forecast, by Test Type
          • 7.3.5.5.3 Market size and forecast, by Age Group
          • 7.3.5.5.4 Market size and forecast, by Distribution Channel
        • 7.3.5.6 Rest of Europe
          • 7.3.5.6.1 Key market trends, growth factors and opportunities
          • 7.3.5.6.2 Market size and forecast, by Test Type
          • 7.3.5.6.3 Market size and forecast, by Age Group
          • 7.3.5.6.4 Market size and forecast, by Distribution Channel
    • 7.4 Asia-Pacific
      • 7.4.1 Key trends and opportunities
      • 7.4.2 Asia-Pacific Market size and forecast, by Test Type
      • 7.4.3 Asia-Pacific Market size and forecast, by Age Group
      • 7.4.4 Asia-Pacific Market size and forecast, by Distribution Channel
      • 7.4.5 Asia-Pacific Market size and forecast, by country
        • 7.4.5.1 Japan
          • 7.4.5.1.1 Key market trends, growth factors and opportunities
          • 7.4.5.1.2 Market size and forecast, by Test Type
          • 7.4.5.1.3 Market size and forecast, by Age Group
          • 7.4.5.1.4 Market size and forecast, by Distribution Channel
        • 7.4.5.2 China
          • 7.4.5.2.1 Key market trends, growth factors and opportunities
          • 7.4.5.2.2 Market size and forecast, by Test Type
          • 7.4.5.2.3 Market size and forecast, by Age Group
          • 7.4.5.2.4 Market size and forecast, by Distribution Channel
        • 7.4.5.3 Australia
          • 7.4.5.3.1 Key market trends, growth factors and opportunities
          • 7.4.5.3.2 Market size and forecast, by Test Type
          • 7.4.5.3.3 Market size and forecast, by Age Group
          • 7.4.5.3.4 Market size and forecast, by Distribution Channel
        • 7.4.5.4 India
          • 7.4.5.4.1 Key market trends, growth factors and opportunities
          • 7.4.5.4.2 Market size and forecast, by Test Type
          • 7.4.5.4.3 Market size and forecast, by Age Group
          • 7.4.5.4.4 Market size and forecast, by Distribution Channel
        • 7.4.5.5 South Korea
          • 7.4.5.5.1 Key market trends, growth factors and opportunities
          • 7.4.5.5.2 Market size and forecast, by Test Type
          • 7.4.5.5.3 Market size and forecast, by Age Group
          • 7.4.5.5.4 Market size and forecast, by Distribution Channel
        • 7.4.5.6 Rest of Asia-Pacific
          • 7.4.5.6.1 Key market trends, growth factors and opportunities
          • 7.4.5.6.2 Market size and forecast, by Test Type
          • 7.4.5.6.3 Market size and forecast, by Age Group
          • 7.4.5.6.4 Market size and forecast, by Distribution Channel
    • 7.5 LAMEA
      • 7.5.1 Key trends and opportunities
      • 7.5.2 LAMEA Market size and forecast, by Test Type
      • 7.5.3 LAMEA Market size and forecast, by Age Group
      • 7.5.4 LAMEA Market size and forecast, by Distribution Channel
      • 7.5.5 LAMEA Market size and forecast, by country
        • 7.5.5.1 Brazil
          • 7.5.5.1.1 Key market trends, growth factors and opportunities
          • 7.5.5.1.2 Market size and forecast, by Test Type
          • 7.5.5.1.3 Market size and forecast, by Age Group
          • 7.5.5.1.4 Market size and forecast, by Distribution Channel
        • 7.5.5.2 Saudi Arabia
          • 7.5.5.2.1 Key market trends, growth factors and opportunities
          • 7.5.5.2.2 Market size and forecast, by Test Type
          • 7.5.5.2.3 Market size and forecast, by Age Group
          • 7.5.5.2.4 Market size and forecast, by Distribution Channel
        • 7.5.5.3 South Africa
          • 7.5.5.3.1 Key market trends, growth factors and opportunities
          • 7.5.5.3.2 Market size and forecast, by Test Type
          • 7.5.5.3.3 Market size and forecast, by Age Group
          • 7.5.5.3.4 Market size and forecast, by Distribution Channel
        • 7.5.5.4 Rest of LAMEA
          • 7.5.5.4.1 Key market trends, growth factors and opportunities
          • 7.5.5.4.2 Market size and forecast, by Test Type
          • 7.5.5.4.3 Market size and forecast, by Age Group
          • 7.5.5.4.4 Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction
    • 8.2. Top winning strategies
    • 8.3. Product Mapping of Top 10 Player
    • 8.4. Competitive Dashboard
    • 8.5. Competitive Heatmap
    • 8.6. Top player positioning, 2021

CHAPTER 9: COMPANY PROFILES

    • 9.1 ACON Laboratories, Inc
      • 9.1.1 Company overview
      • 9.1.2 Key Executives
      • 9.1.3 Company snapshot
      • 9.1.4 Operating business segments
      • 9.1.5 Product portfolio
      • 9.1.6 Business performance
      • 9.1.7 Key strategic moves and developments
    • 9.2 Quidel Corporation
      • 9.2.1 Company overview
      • 9.2.2 Key Executives
      • 9.2.3 Company snapshot
      • 9.2.4 Operating business segments
      • 9.2.5 Product portfolio
      • 9.2.6 Business performance
      • 9.2.7 Key strategic moves and developments
    • 9.3 Biomerieux SA
      • 9.3.1 Company overview
      • 9.3.2 Key Executives
      • 9.3.3 Company snapshot
      • 9.3.4 Operating business segments
      • 9.3.5 Product portfolio
      • 9.3.6 Business performance
      • 9.3.7 Key strategic moves and developments
    • 9.4 Everly Health, Inc
      • 9.4.1 Company overview
      • 9.4.2 Key Executives
      • 9.4.3 Company snapshot
      • 9.4.4 Operating business segments
      • 9.4.5 Product portfolio
      • 9.4.6 Business performance
      • 9.4.7 Key strategic moves and developments
    • 9.5 OraSure Technologies, Inc
      • 9.5.1 Company overview
      • 9.5.2 Key Executives
      • 9.5.3 Company snapshot
      • 9.5.4 Operating business segments
      • 9.5.5 Product portfolio
      • 9.5.6 Business performance
      • 9.5.7 Key strategic moves and developments
    • 9.6 PHC Holdings Corporation
      • 9.6.1 Company overview
      • 9.6.2 Key Executives
      • 9.6.3 Company snapshot
      • 9.6.4 Operating business segments
      • 9.6.5 Product portfolio
      • 9.6.6 Business performance
      • 9.6.7 Key strategic moves and developments
    • 9.7 B. Braun Melsungen AG
      • 9.7.1 Company overview
      • 9.7.2 Key Executives
      • 9.7.3 Company snapshot
      • 9.7.4 Operating business segments
      • 9.7.5 Product portfolio
      • 9.7.6 Business performance
      • 9.7.7 Key strategic moves and developments
    • 9.8 Cardinal Health Inc.
      • 9.8.1 Company overview
      • 9.8.2 Key Executives
      • 9.8.3 Company snapshot
      • 9.8.4 Operating business segments
      • 9.8.5 Product portfolio
      • 9.8.6 Business performance
      • 9.8.7 Key strategic moves and developments
    • 9.9 Abbott Laboratories
      • 9.9.1 Company overview
      • 9.9.2 Key Executives
      • 9.9.3 Company snapshot
      • 9.9.4 Operating business segments
      • 9.9.5 Product portfolio
      • 9.9.6 Business performance
      • 9.9.7 Key strategic moves and developments
    • 9.10 F. Hoffmann-La Roche Ltd.
      • 9.10.1 Company overview
      • 9.10.2 Key Executives
      • 9.10.3 Company snapshot
      • 9.10.4 Operating business segments
      • 9.10.5 Product portfolio
      • 9.10.6 Business performance
      • 9.10.7 Key strategic moves and developments

 

LIST OF TABLES

  • TABLE 1. GLOBAL AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 2. AT-HOME TESTING MARKET FOR GLUCOSE TEST KITS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 3. AT-HOME TESTING MARKET FOR INFECTIOUS DISEASES TEST KITS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 4. AT-HOME TESTING MARKET FOR PREGNANCY TEST KITS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 5. AT-HOME TESTING MARKET FOR CHOLESTEROL TEST STRIPS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 6. AT-HOME TESTING MARKET FOR DRUGS OF ABUSE TEST KITS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 7. AT-HOME TESTING MARKET FOR COAGULATION MONITORING TESTS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 8. AT-HOME TESTING MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 9. GLOBAL AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 10. AT-HOME TESTING MARKET FOR PEDIATRIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 11. AT-HOME TESTING MARKET FOR ADULT, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 12. AT-HOME TESTING MARKET FOR GERIATRIC, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 13. GLOBAL AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 14. AT-HOME TESTING MARKET FOR RETAIL PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 15. AT-HOME TESTING MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 16. AT-HOME TESTING MARKET FOR ONLINE PHARMACIES, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 17. AT-HOME TESTING MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
  • TABLE 18. NORTH AMERICA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 19. NORTH AMERICA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 20. NORTH AMERICA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 21. NORTH AMERICA AT-HOME TESTING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 22. U.S. AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 23. U.S. AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 24. U.S. AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 25. CANADA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 26. CANADA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 27. CANADA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 28. MEXICO AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 29. MEXICO AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 30. MEXICO AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 31. EUROPE AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 32. EUROPE AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 33. EUROPE AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 34. EUROPE AT-HOME TESTING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 35. GERMANY AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 36. GERMANY AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 37. GERMANY AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 38. FRANCE AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 39. FRANCE AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 40. FRANCE AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 41. UK AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 42. UK AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 43. UK AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 44. ITALY AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 45. ITALY AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 46. ITALY AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 47. SPAIN AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 48. SPAIN AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 49. SPAIN AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 50. REST OF EUROPE AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 51. REST OF EUROPE AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 52. REST OF EUROPE AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 53. ASIA-PACIFIC AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 54. ASIA-PACIFIC AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 55. ASIA-PACIFIC AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 56. ASIA-PACIFIC AT-HOME TESTING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 57. JAPAN AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 58. JAPAN AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 59. JAPAN AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 60. CHINA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 61. CHINA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 62. CHINA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 63. AUSTRALIA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 64. AUSTRALIA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 65. AUSTRALIA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 66. INDIA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 67. INDIA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 68. INDIA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 69. SOUTH KOREA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 70. SOUTH KOREA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 71. SOUTH KOREA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 72. REST OF ASIA-PACIFIC AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 73. REST OF ASIA-PACIFIC AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 74. REST OF ASIA-PACIFIC AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 75. LAMEA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 76. LAMEA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 77. LAMEA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 78. LAMEA AT-HOME TESTING MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
  • TABLE 79. BRAZIL AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 80. BRAZIL AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 81. BRAZIL AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 82. SAUDI ARABIA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 83. SAUDI ARABIA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 84. SAUDI ARABIA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 85. SOUTH AFRICA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 86. SOUTH AFRICA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 87. SOUTH AFRICA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 88. REST OF LAMEA AT-HOME TESTING MARKET, BY TEST TYPE, 2021-2031 (REVENUE, $MILLION)
  • TABLE 89. REST OF LAMEA AT-HOME TESTING MARKET, BY AGE GROUP, 2021-2031 (REVENUE, $MILLION)
  • TABLE 90. REST OF LAMEA AT-HOME TESTING MARKET, BY DISTRIBUTION CHANNEL, 2021-2031 (REVENUE, $MILLION)
  • TABLE 91. ACON LABORATORIES, INC: KEY EXECUTIVES
  • TABLE 92. ACON LABORATORIES, INC: COMPANY SNAPSHOT
  • TABLE 93. ACON LABORATORIES, INC: OPERATING SEGMENTS
  • TABLE 94. ACON LABORATORIES, INC: PRODUCT PORTFOLIO
  • TABLE 95. ACON LABORATORIES, INC: NET SALES
  • TABLE 96. ACON LABORATORIES, INC: KEY STRATERGIES
  • TABLE 97. QUIDEL CORPORATION: KEY EXECUTIVES
  • TABLE 98. QUIDEL CORPORATION: COMPANY SNAPSHOT
  • TABLE 99. QUIDEL CORPORATION: OPERATING SEGMENTS
  • TABLE 100. QUIDEL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 101. QUIDEL CORPORATION: NET SALES
  • TABLE 102. QUIDEL CORPORATION: KEY STRATERGIES
  • TABLE 103. BIOMERIEUX SA: KEY EXECUTIVES
  • TABLE 104. BIOMERIEUX SA: COMPANY SNAPSHOT
  • TABLE 105. BIOMERIEUX SA: OPERATING SEGMENTS
  • TABLE 106. BIOMERIEUX SA: PRODUCT PORTFOLIO
  • TABLE 107. BIOMERIEUX SA: NET SALES
  • TABLE 108. BIOMERIEUX SA: KEY STRATERGIES
  • TABLE 109. EVERLY HEALTH, INC: KEY EXECUTIVES
  • TABLE 110. EVERLY HEALTH, INC: COMPANY SNAPSHOT
  • TABLE 111. EVERLY HEALTH, INC: OPERATING SEGMENTS
  • TABLE 112. EVERLY HEALTH, INC: PRODUCT PORTFOLIO
  • TABLE 113. EVERLY HEALTH, INC: NET SALES
  • TABLE 114. EVERLY HEALTH, INC: KEY STRATERGIES
  • TABLE 115. ORASURE TECHNOLOGIES, INC: KEY EXECUTIVES
  • TABLE 116. ORASURE TECHNOLOGIES, INC: COMPANY SNAPSHOT
  • TABLE 117. ORASURE TECHNOLOGIES, INC: OPERATING SEGMENTS
  • TABLE 118. ORASURE TECHNOLOGIES, INC: PRODUCT PORTFOLIO
  • TABLE 119. ORASURE TECHNOLOGIES, INC: NET SALES
  • TABLE 120. ORASURE TECHNOLOGIES, INC: KEY STRATERGIES
  • TABLE 121. PHC HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 122. PHC HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 123. PHC HOLDINGS CORPORATION: OPERATING SEGMENTS
  • TABLE 124. PHC HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 125. PHC HOLDINGS CORPORATION: NET SALES
  • TABLE 126. PHC HOLDINGS CORPORATION: KEY STRATERGIES
  • TABLE 127. B. BRAUN MELSUNGEN AG: KEY EXECUTIVES
  • TABLE 128. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 129. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 130. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 131. B. BRAUN MELSUNGEN AG: NET SALES
  • TABLE 132. B. BRAUN MELSUNGEN AG: KEY STRATERGIES
  • TABLE 133. CARDINAL HEALTH INC.: KEY EXECUTIVES
  • TABLE 134. CARDINAL HEALTH INC.: COMPANY SNAPSHOT
  • TABLE 135. CARDINAL HEALTH INC.: OPERATING SEGMENTS
  • TABLE 136. CARDINAL HEALTH INC.: PRODUCT PORTFOLIO
  • TABLE 137. CARDINAL HEALTH INC.: NET SALES
  • TABLE 138. CARDINAL HEALTH INC.: KEY STRATERGIES
  • TABLE 139. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 140. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 141. ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 142. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 143. ABBOTT LABORATORIES: NET SALES
  • TABLE 144. ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 145. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 146. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 147. F. HOFFMANN-LA ROCHE LTD.: OPERATING SEGMENTS
  • TABLE 148. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 149. F. HOFFMANN-LA ROCHE LTD.: NET SALES
  • TABLE 150. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1. SEGMENTATION OF AT-HOME TESTING MARKET,2021-2031
  • FIGURE 2. AT-HOME TESTING MARKET,2021-2031
  • FIGURE 3. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 4. PORTER FIVE-1
  • FIGURE 5. PORTER FIVE-2
  • FIGURE 6. PORTER FIVE-3
  • FIGURE 7. PORTER FIVE-4
  • FIGURE 8. PORTER FIVE-5
  • FIGURE 9. AT-HOME TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 10. AT-HOME TESTING MARKET,BY TEST TYPE,2021(%)
  • FIGURE 11. COMPARATIVE SHARE ANALYSIS OF GLUCOSE TEST KITS AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF INFECTIOUS DISEASES TEST KITS AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PREGNANCY TEST KITS AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF CHOLESTEROL TEST STRIPS AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF DRUGS OF ABUSE TEST KITS AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF COAGULATION MONITORING TESTS AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF OTHERS AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 18. AT-HOME TESTING MARKET,BY AGE GROUP,2021(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PEDIATRIC AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF ADULT AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF GERIATRIC AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 22. AT-HOME TESTING MARKET,BY DISTRIBUTION CHANNEL,2021(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF RETAIL PHARMACIES AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HOSPITAL PHARMACIES AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 25. COMPARATIVE SHARE ANALYSIS OF ONLINE PHARMACIES AT-HOME TESTING MARKET, 2021 AND 2031(%)
  • FIGURE 26. AT-HOME TESTING MARKET BY REGION,2021
  • FIGURE 27. U.S. AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 28. CANADA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 29. MEXICO AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 30. GERMANY AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 31. FRANCE AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 32. UK AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 33. ITALY AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 34. SPAIN AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 35. REST OF EUROPE AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 36. JAPAN AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 37. CHINA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 38. AUSTRALIA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 39. INDIA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 40. SOUTH KOREA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 41. REST OF ASIA-PACIFIC AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 42. BRAZIL AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 43. SAUDI ARABIA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 44. SOUTH AFRICA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 45. REST OF LAMEA AT-HOME TESTING MARKET,2021-2031($MILLION)
  • FIGURE 46. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 50. COMPETITIVE DASHBOARD
  • FIGURE 51. COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 52. TOP PLAYER POSITIONING, 2021
  • FIGURE 53. ACON LABORATORIES, INC.: NET SALES ($MILLION)
  • FIGURE 54. QUIDEL CORPORATION.: NET SALES ($MILLION)
  • FIGURE 55. BIOMERIEUX SA.: NET SALES ($MILLION)
  • FIGURE 56. EVERLY HEALTH, INC.: NET SALES ($MILLION)
  • FIGURE 57. ORASURE TECHNOLOGIES, INC.: NET SALES ($MILLION)
  • FIGURE 58. PHC HOLDINGS CORPORATION.: NET SALES ($MILLION)
  • FIGURE 59. B. BRAUN MELSUNGEN AG.: NET SALES ($MILLION)
  • FIGURE 60. CARDINAL HEALTH INC..: NET SALES ($MILLION)
  • FIGURE 61. ABBOTT LABORATORIES.: NET SALES ($MILLION)
  • FIGURE 62. F. HOFFMANN-LA ROCHE LTD..: NET SALES ($MILLION)

 

SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5730

This license allows only one user to access the PDF.
Electronic (PDF)

$9600

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)

OUR CUSTOMER

Novocure

RELATED REPORTS

Global Magnetic-Guided Capsule Endoscopy Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-11M2929
Fri Apr 28 00:00:00 UTC 2023

Add to Cart

Global Dressing Tables Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-39R3443
Fri Apr 28 00:00:00 UTC 2023

Add to Cart

Global Pilot Glasses Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-35A3503
Fri Apr 28 00:00:00 UTC 2023

Add to Cart

Global Magnetic-Guided Capsule Endoscopy System Market Research Report 2023

120 Pages
Type: Report
Code: QYRE-Auto-31X3450
Fri Apr 28 00:00:00 UTC 2023

Add to Cart